Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A cis-acting mechanism mediates trancriptional memory at Polycomb target genes in mammals

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE147568 | GEO | 2021/08/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

A cis-acting mechanism mediates trancriptional memory at Polycomb target genes in mammals [WGBS]

Project description:Epigenetic inheritance of gene expression states enables a single genome to maintain distinct cellular identities. How histone modifications contribute to this process remains unclear. Using global chromatin perturbations and local, time-controlled modulation of transcription, we establish the existence of epigenetic memory of transcriptional activation for genes that can be silenced by the Polycomb group. This property emerges during cell differentiation and allows genes to be stably switched following a transient transcriptional stimulus. This transcriptional memory state at Polycomb targets operates in cis; however, rather than relying solely on read-and-write propagation of histone modifications, the memory is also linked to the strength of activating input opposing Polycomb proteins and therefore varies with the cellular context. Our data and computational simulations suggest a model whereby transcriptional memory arises from double-negative feedback between Polycomb-mediated silencing and active transcription. Epigenetic memory at Polycomb targets thus depends not only on histone modifications but also on the gene-regulatory network and underlying identity of a cell.

2021-08-19 | GSE169535 | GEO

A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals

Project description:NPCs were cultured in the presence of small-molecule inhibitors of PRC2, and the post-translational modification status of histone H3 at lysines 27 and 36 was analyzed by quantitative mass spectrometry to verify the efficacy of the treatment.

2021-08-19 | PXD023966 | Pride